Watson 372 50 mg Pill - blue & white capsule/oblong, 19mm
Pill with imprint Watson 372 50 mg is Blue & White, Capsule/Oblong and has been identified as Loxapine Succinate 50 mg. It is supplied by Watson Laboratories, Inc.
Loxapine is used in the treatment of Agitation; Agitated State; Schizophrenia and belongs to the drug class miscellaneous antipsychotic agents. FDA has not classified the drug for risk during pregnancy. Loxapine 50 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Watson 372 50 mg




Loxapine Succinate
- Imprint
- Watson 372 50 mg
- Strength
- 50 mg
- Color
- Blue & White
- Size
- 19.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Miscellaneous antipsychotic agents
- Pregnancy Category
- N - Not classified
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Watson Laboratories, Inc.
- Inactive Ingredients
-
lactose anhydrous,
benzyl alcohol,
butylparaben,
edetate calcium disodium,
gelatin,
magnesium stearate,
methylparaben,
polacrilin potassium,
propylparaben,
sodium lauryl sulfate,
sodium propionate,
magnesium silicate,
titanium dioxide,
FD&C Blue No. 1
Note: Inactive ingredients may vary.
Labelers / Repackagers
NDC Code | Labeler / Repackager |
---|---|
00591-0372 | Watson Pharmaceuticals, Inc. |
51079-0903 (Discontinued) | UDL Laboratories Inc. |
Related images for "Watson 372 50 mg"
More about loxapine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (22)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous antipsychotic agents
- Breastfeeding
- En español
Patient resources
- Loxapine drug information
- Loxapine (Inhalation) (Advanced Reading)
- Loxapine (Oral) (Advanced Reading)
- Loxapine Capsules
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.